Welch Allyn launches Class I recall
This article was originally published in The Silver Sheet
Executive Summary
Welch Allyn has recalled 1,794 AED 10 automated external defibrillators because of a possibility that the devices may fail to deliver appropriate shocks for resuscitation. AED 10s manufactured at the firm's Beaverton, Ore., facility between March 29, 2007, and Aug. 9, 2007, may contain defective capacitors affecting a patient's ECG reading. The firm, which launched the recall Oct. 26, says no adverse events have occurred as a result of the error. The Class I recall comes on the heels of the firm's Aug. 24 Class I recall of its AED 20 automated external defibrillators, and previous Class I recalls for the AED 20 in June 2006 and May 2005
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.